Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review
Journal of Thoracic Disease · 2024-02 · 16 (2) · 1503-1520
DOI: 10.21037/jtd-23-1626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thoracic Disease, 2024-02. Verfasst von Orlando R Suero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Cardiovascular Anesthesia & Critical Care Medicine, Department of Anesthesiology, Baylor College of Medicine, Houston, TX, USA. Die Arbeit wurde bisher 82-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Postoperative atrial fibrillation (POAF) after cardiac surgery is associated with elevated morbidity and mortality. Although current prediction models have limited efficacy, several perioperative interventions can reduce patients' risk of POAF. These begin with preoperative medications, including beta-blockers and amiodarone. Moreover, patients should be screened for preexisting atrial fibrillation (AF) so that concomitant surgical ablation and left atrial appendage occlusion can be performed in appropriate candidates. Intraoperative interventions such as posterior pericardiectomy can reduce mediastinal fluid accumulation, which is a trigger for POAF. Furthermore, many preventive strategies for POAF are implemented in the immediate postoperative period. Initiating beta-blockers, amiodarone, or both is reasonable for most patients. Overdrive atrial pacing, colchicine, and steroids have been used by some, although the evidence base is less robust. For patients with POAF, rate-control and rhythm-control strategies have comparable outcomes. Decision-making regarding anticoagulation should recognize that the stroke risk associated with POAF appears to be lower than that for general nonvalvular AF. The evidence that oral anticoagulation reduces stroke risk is less clear for POAF patients than for patients with general nonvalvular AF. Given that POAF tends to be shorter-lived and is associated with greater bleeding risks in the perioperative period, decisions regarding anticoagulation should be individualized. Finally, wearable technology and machine learning algorithms for better predicting and managing POAF appear to be coming soon. These technologies and a comprehensive clinical program could meaningfully reduce the incidence of this common complication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Divisions of Cardiovascular Anesthesia & Critical Care Medicine, Department of Anesthesiology, Baylor College of Medicine, Houston, TX, USA.
- Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
- Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, TX, USA.
- Department of Cardiology, The Texas Heart Institute, Houston, TX, USA.
- Division of General Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Zitieren
APA
Suero, O. R., Ali, A. K., Barron, L. R., Segar, M. W., Moon, M. R., & Chatterjee, S. (2024). Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review. Journal of Thoracic Disease, 16(2), 1503-1520. https://doi.org/10.21037/jtd-23-1626
Vancouver
Suero OR, Ali AK, Barron LR, Segar MW, Moon MR, Chatterjee S. Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review. Journal of Thoracic Disease. 2024;16(2):1503-1520. doi:10.21037/jtd-23-1626
BibTeX
@article{Suero2024,
author = {Suero, Orlando R and Ali, Ahmed K and Barron, Lauren R and Segar, Matthew W and Moon, Marc R and Chatterjee, Subhasis},
title = {Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review},
journal = {Journal of Thoracic Disease},
year = {2024},
volume = {16},
number = {2},
pages = {1503--1520},
doi = {10.21037/jtd-23-1626}
}
EUVIMED